A method of isolating a non-diffusible and local-paralyzing botulinum toxin subfraction from conventional toxin preparations for clinical use
KR20090091501A
Method of purifying botulinum toxin from clostridium botulinum
KR20050113739A
Glycosylated immunoglobulin and immunoadhesin comprising the same
KR20050082389A
Pharmaceutical composition for treatment of transplantation rejection comprising concatameric immunoadhesin
KR20050013024A
A method of improving efficacy of biological response-modifying proteins and the example muteins
KR20040009997A
Concatameric immunoadhesin
KR20030010189A
METHOD OF MANUFACTURING Ig-FUSION PROTEINS BY CONCATAMERIZATION, TNFR/Fc FUSION PROTEINS MANUFACTURED BY THE METHOD, DNA CODING THE PROTEINS, VECTORS INCLUDING THE DNA, AND CELLS TRANSFORMED BY THE VECTOR
